When does Biophytis report earnings and why does it matter for ALBPS.PA stock?

Biophytis reports earnings on 23 Feb 2026. The release matters because clinical progress, cash runway and financing guidance can cause sharp intraday moves in ALBPS.PA stock.

What is the current price and liquidity for ALBPS.PA stock?

ALBPS.PA stock trades at €0.0548 with volume around 542,809 today versus average volume 695,656. Lower liquidity can widen spreads and increase execution risk.

How does Meyka AI grade ALBPS.PA stock and what does it mean?

Meyka AI rates ALBPS.PA **70.97 (B+, BUY)**. The grade blends benchmarks, sector and company metrics and signals potential upside balanced by operational risks. It is informational, not investment advice.

What forecast does Meyka AI give for ALBPS.PA stock?

Meyka AI's forecast model projects **€2.20497** over one year. Compared with the current price €0.0548 this implies an estimated upside of about **3924.51%**, with model-based risks and no guarantees.

EU Stocks

ALBPS.PA stock falls ahead of earnings: key metrics and forecast ahead of 23 Feb 2026

ByDanny Kontos February 18, 2026February 18, 2026

ALBPS.PA stock trades at €0.0548 intraday and is down 5.52% as investors position before Biophytis S.A.’s earnings release on 23 Feb 2026. The Paris-listed biotech (EURONEXT, Europe) has a market cap of €1,321,831.00 and posted EPS -0.34 last reported. With low liquidity and a 50-day average price of €0.07, the stock shows elevated volatility. This earnings spotlight focuses on catalysts, key ratios, Meyka AI grading and a model forecast to frame risk and opportunity ahead of the report.